November 27, 2025
1,998
10
3
0.65%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:26Now PlayingWhat if the future of weightloss drugs didn’t involve needles at all? Drugmakers are testing onceaday pills and nextgen GLP1 injectables that could be easier to use, cheaper to distribute and available to far more people. One expert we spoke with said this could be a “Henry Ford moment” for obesity treatment with potential benefits beyond weight loss, including improvements in inflammation and metabolic health. Business of Medicine reporter Daniel Gilbert explains what this could mean for patients. Subscribe to The Washington Post on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.